Edition:
United States

People: GlaxoSmithKline PLC (GSK)

GSK on New York Consolidated

40.62USD
23 Oct 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$40.62
Open
--
Day's High
--
Day's Low
--
Volume
600
Avg. Vol
3,063,215
52-wk High
$44.53
52-wk Low
$37.20

Dingemans, Simon 

Mr. Simon Dingemans is Chief Financial Officer, Executive Director of GlaxoSmithKline Plc. Prior to joining GSK, Simon had over 25 years of experience in investment banking at SG Warburg and Goldman Sachs. Simon advised GSK for over a decade before his appointment and was closely involved in a number of GSK’s key strategic projects. Simon is Deputy Chairman of the 100 Group of Finance Directors, having been Chairman from 2014 to early 2017.

Basic Compensation

Total Annual Compensation, GBP 1,651,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP 119,000
All Other, GBP 1,358,000
Fiscal Year Total, GBP 3,128,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --